AzTrials
AzTrials

Cerebral Vascular DisorderQAP-AVCNCT03689387

Evaluation of Physical Activity Practice (AP) After Cerebral Vascular Stroke (Stroke)

An observational study of Cerebral Vascular Disorder, run by Centre Hospitalier Universitaire, Amiens at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Physical activity is defined by any movement produced by the skeletal muscles responsible for an increase in energy expenditure. The Stroke Council of the American Heart Association (AHA) recommends, in prevention after the occurrence of a first stroke, the practice of moderate to intense physical activity for 40… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Cerebral Vascular Disorder
What is being tested?
the Medical Program Information Systems (PMSI)
How many people
50 participants
Where
1 siteFrance
Study dates
23 Oct 2017to 23 Apr 2018
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: All other patients hospitalized in the department of Neurological MPR in the wake of a stroke, or who have been summoned to a post-stroke consultation by the Neurological MPR department of the University Hospital of Amiens, will initially be included.

Who may be able to join

  • Patients over 18 years of age when completing the questionnaire.
  • Have had ischemic or hemorrhagic stroke confirmed by MRI or CT scan.
  • Hospitalized in the Department of Neurological MPR of Amiens University Hospital, or having received a consultation in MPR at Amiens University Hospital after returning home.
  • Not institutionalized

Who cannot join

  • Patients over 18 years of age when completing the questionnaire.
  • Have had ischemic or hemorrhagic stroke confirmed by MRI or CT scan.
  • Hospitalized in the Department of Neurological MPR of Amiens University Hospital, or having received a consultation in MPR at Amiens University Hospital after returning home.
  • Not institutionalized

Trial locations and contacts

1 site in 1 country.

France1 site
  • Chu Amiens Picardie

    Amiens

Other trials in France

About this study

Physical activity is defined by any movement produced by the skeletal muscles responsible for an increase in energy expenditure.

The Stroke Council of the American Heart Association (AHA) recommends, in prevention after the occurrence of a first stroke, the practice of moderate to intense physical activity for 40 minutes a day, three to four times a week (Lackland et al., 2014). The World Health Organization (WHO) also recommends the practice of at least 150 minutes of moderate-intensity endurance activity or at least 75 minutes of endurance activity of sustained intensity per week, adapted to the possibilities of the patient (World Health Organization 2010). Unfortunately, the majority of stroke patients have activity below recommendation (Rand et al., 2009).

Read more

The main hypothesis of this work is that the amount of AP, measured by self-questionnaire, is insufficient, and below current recommendations in patients with stroke, after return home.

Given the multiple physical, psychological, social, and economic benefits of PA practice, it is also important to identify the habits and challenges that patients experience with PA, so that they can be better informed. advise and guide them to reach AP stroke recommendations.

Read the detailed description

Physical activity is defined by any movement produced by the skeletal muscles responsible for an increase in energy expenditure. It brings many benefits after stroke, particularly in terms of secondary prevention by reducing modifiable risk factors, cardio-respiratory capacity, and neuromotive, cognitive and functional recovery by stimulating brain plasticity (Saunders et al., 2014).

The Stroke Council of the American Heart Association (AHA) recommends, in prevention after the occurrence of a first stroke, the practice of moderate to intense physical activity for 40 minutes a day, three to four times a week (Lackland et al., 2014). The World Health Organization (WHO) also recommends the practice of at least 150 minutes of moderate-intensity endurance activity or at least 75 minutes of endurance activity of sustained intensity per week, adapted to the possibilities of the patient (World Health Organization 2010). Unfortunately, the majority of stroke patients have activity below recommendation (Rand et al., 2009).

The main hypothesis of this work is that the amount of AP, measured by self-questionnaire, is insufficient, and below current recommendations in patients with stroke, after return home.

Given the multiple physical, psychological, social, and economic benefits of PA practice, it is also important to identify the habits and challenges that patients experience with PA, so that they can be better informed. advise and guide them to reach AP stroke recommendations.

Being tested
the Medical Program Information Systems (PMSI)
Keywords
cerebral vascular stroke, activity practice
Medical subject headings
Cerebrovascular Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • the Medical Program Information Systems (PMSI)Other

    The selection of the files will be carried out using the Medical Program Information Systems (PMSI) and search convocations for post-stroke follow-up consultations conducted by the Secretariat of Neurological MPR Amiens University Hospital.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. AP in the aftermath of a stroke

    The objective of this study is to Quantify the Physical Activity (PA) level to patients in the aftermath of a stroke after returning homeduring the rehabilitation treatment.

    Measured: 36 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Sep 2018
  2. Study start23 Oct 2017
  3. Primary completion23 Apr 2018
  4. Study completion23 Apr 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Retrospective
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03689387
Sponsor's protocol ID
PI2017_843_0017
Acronym
QAP-AVC
Status last verified
Sep 2018
First submitted
27 Sep 2018
Last updated
17 May 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Cerebral Vascular Disorder, run by Centre Hospitalier Universitaire, Amiens at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 May 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

AP in the aftermath of a stroke (time frame: 36 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 May 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in